Evidence map›Paper›PMID 38515764›Full record

ArticleAngewandte Chemie (Weinheim an der Bergstrasse, Germany)2023

Fluorogenic Granzyme A Substrates Enable Real-Time Imaging of Adaptive Immune Cell Activity.

Zhiming Cheng, Emily J Thompson, Lorena Mendive-Tapia, Jamie I Scott, Sam Benson, Takanori Kitamura, Ana Senan-Salinas, Youhani Samarakoon, Edward W Roberts, Maykel A Arias and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Zhiming ChengCentre for Inflammation Research The University of Edinburgh Edinburgh UK.
Emily J ThompsonCentre for Inflammation Research The University of Edinburgh Edinburgh UK.
Lorena Mendive-TapiaCentre for Inflammation Research The University of Edinburgh Edinburgh UK.
Jamie I ScottCentre for Inflammation Research The University of Edinburgh Edinburgh UK.
Sam BensonCentre for Inflammation Research The University of Edinburgh Edinburgh UK.
Takanori KitamuraMRC Centre for Reproductive Health The University of Edinburgh Edinburgh UK.
Ana Senan-SalinasInstituto de Carboquimica CSIC Zaragoza Spain.
Youhani SamarakoonCancer Research UK Beatson Institute Glasgow UK.
Edward W RobertsCancer Research UK Beatson Institute Glasgow UK.
Maykel A AriasCIBERINFEC Instituto de Salud Carlos III Zaragoza Spain.
Julian PardoCIBERINFEC Instituto de Salud Carlos III Zaragoza Spain.
Eva M GalvezInstituto de Carboquimica CSIC Zaragoza Spain.
Marc VendrellCentre for Inflammation Research The University of Edinburgh Edinburgh UK.ORCID 0000-0002-5392-9740
Centre for Inflammation Research · GBInstituto de Salud Carlos III · ESCancer Research UK Scotland Institute · GBInstituto de Carboquímica · ESMRC Centre for Reproductive Health · GB

Funding

Medical Research Council MR/S006982/1
6 · The paper itself

Abstract

Cytotoxic immune cells, including T lymphocytes (CTLs) and natural killer (NK) cells, are essential components of the host response against tumors. CTLs and NK cells secrete granzyme A (GzmA) upon recognition of cancer cells; however, there are very few tools that can detect physiological levels of active GzmA with high spatiotemporal resolution. Herein, we report the rational design of the near-infrared fluorogenic substrates for human GzmA and mouse GzmA. These activity-based probes display very high catalytic efficiency and selectivity over other granzymes, as shown in tissue lysates from wild-type and GzmA knock-out mice. Furthermore, we demonstrate that the probes can image how adaptive immune cells respond to antigen-driven recognition of cancer cells in real time.

Indexed as

CancerFluorescenceHemicyaninePeptidesProbes

Identifiers

PMID38515764
PMCPMC10953043
OpenAlexW4312165064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.